California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on July 6, 2026

Jul. 6, 2026

RheoSense Celebrates 25 Years of Viscosity Measurement Technology

Indeterminate EIN Presswire

Jul. 6, 2026

Victim Rights Law Center Backs McGrath Kavinoky LLP to Protect Survivors' Medical Records in Cedars-Sinai Abuse Case

Indeterminate EIN Presswire

Jul. 6, 2026

Tina Bernard, Creator of The Badass Arts™, Challenges Myth That Women Over 40 Lack Ambition, Says They’re More Driven

Indeterminate EIN Presswire

Jul. 6, 2026

Invision Diagnostics Expands Women's Health Offerings with CureMetrix's cmAngio®

Indeterminate EIN Presswire

Jul. 6, 2026

HeartLung Launches 'Why Pay More and Get Less?' Campaign at SCCT 2026

Indeterminate EIN Presswire

Jul. 6, 2026

Cognos Therapeutics Appoints Innovobot U.S. Labs Executive Miguel Adao to Its Industry Advisory Board

Indeterminate EIN Presswire

Jul. 6, 2026

Custom Medical Blades: Baucor® Expands Precision Manufacturing for Healthcare OEMs

Indeterminate EIN Presswire

Jul. 6, 2026

Never Give Up Day lleva su movimiento a millones de hispanohablantes con el lanzamiento de Día de Nunca Rendirse

Indeterminate EIN Presswire

Jul. 6, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Indeterminate GlobeNewswire

Jul. 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Indeterminate GlobeNewswire

Jul. 6, 2026

Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker

Indeterminate GlobeNewswire

Jul. 6, 2026

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire